Glyceol


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 61.4%
Ill-defined Disorder 19.6%
Constipation 3.5%
Infection 3.5%
Pyrexia 3.5%
Encephalitis Herpes 2.4%
Epilepsy 1.5%
Brain Neoplasm 1.0%
Convulsion 0.5%
Fluid Replacement 0.5%
Gastric Ulcer 0.5%
Diuretic Therapy 0.3%
Embolic Stroke 0.3%
Neutropenic Sepsis 0.3%
Acute Lymphocytic Leukaemia 0.2%
Brain Oedema 0.2%
Hyperglycaemia 0.2%
Hypertension 0.2%
Neutropenia 0.2%
Polyuria 0.2%
Drug Rash With Eosinophilia And Systemic Symptoms 51.6%
Drug Reaction With Eosinophilia And Systemic Symptoms 16.1%
Urine Output Decreased 9.7%
Prothrombin Level Decreased 6.5%
White Blood Cell Count Decreased 6.5%
Blood Urine Present 3.2%
Renal Impairment 3.2%
Venoocclusive Liver Disease 3.2%
Concomitant
Prophylaxis 18.5%
Product Used For Unknown Indication 14.5%
Drug Use For Unknown Indication 9.2%
Hypertension 7.3%
Brain Oedema 6.4%
Embolic Stroke 5.8%
Cerebral Infarction 4.6%
Thrombotic Cerebral Infarction 3.6%
Pneumonia 3.5%
Anorexia 2.9%
Glioblastoma Multiforme 2.8%
Prophylaxis Against Gastrointestinal Ulcer 2.8%
Metastases To Bone 2.7%
Constipation 2.4%
Nausea 2.4%
Cerebral Toxoplasmosis 2.2%
Gastric Ulcer 2.2%
Hiv Infection 2.2%
Cerebral Haemorrhage 2.1%
Breast Cancer Recurrent 2.0%
White Blood Cell Count Decreased 13.7%
Rhabdomyolysis 9.8%
Hepatic Function Abnormal 7.1%
Haemorrhagic Cerebral Infarction 6.6%
Renal Failure Acute 6.6%
Liver Disorder 6.0%
Cerebral Infarction 5.5%
Pneumonia 5.5%
Brain Oedema 4.9%
Vomiting 4.4%
White Blood Cell Count Increased 4.4%
Platelet Count Decreased 3.8%
Urinary Retention 3.8%
Brain Neoplasm 2.7%
Hydrocephalus 2.7%
Pyrexia 2.7%
Septic Shock 2.7%
Subarachnoid Haemorrhage 2.7%
Encephalitis 2.2%
Glioblastoma 2.2%

Drug Data